Kamrani A, Nasiri H, Hassanzadeh A, Ahmadian Heris J, Mohammadinasab R, Sadeghvand S, Sadeghi M, et al. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses. Cell Commun Signal. 2024;22(1):56.

Article  PubMed  PubMed Central  Google Scholar 

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.

Article  PubMed  CAS  Google Scholar 

Gao W, Bigham A, Ghomi M, Zarrabi A, Rabiee N, Saeb MR, Nuri Ertas Y, et al. Micelle-engineered nanoplatforms for precision oncology. Chem Eng J. 2024;495: 153438.

Article  CAS  Google Scholar 

Rezapour S, Hosseinzadeh E, Marofi F, Hassanzadeh A. Epigenetic-based therapy for colorectal cancer: prospect and involved mechanisms. J Cell Physiol. 2019;234(11):19366–83.

Article  PubMed  CAS  Google Scholar 

Lu Q, Kou D, Lou S, Ashrafizadeh M, Aref AR, Canadas I, Tian Y, et al. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J Hematol Oncol. 2024;17(1):16.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Pang S, Liu X, Dong Z, Tian Y, Ashrafizadeh M, Rabiee N, et al. Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: combination cancer chemotherapy, immunotherapy and gene therapy. Int J Biol Macromol. 2024;273: 132579.

Article  PubMed  CAS  Google Scholar 

Dai J, Ashrafizadeh M, Aref AR, Sethi G, Ertas YN. Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy. Drug Discov Today. 2024;29(7): 103981.

Article  PubMed  CAS  Google Scholar 

Yan H, Chen W, Ge K, Mao X, Li X, Liu W, Wu J, et al. Value of plasma methylated SFRP2 in prognosis of gastric cancer. Dig Dis Sci. 2021;66:3854–61.

Article  PubMed  CAS  Google Scholar 

Zhang X, Huang T, Li Y, Qiu H. Upregulation of THBS1 is related to immunity and chemotherapy resistance in gastric cancer. Int J Gen Med. 2021;1:4945–57.

Article  Google Scholar 

Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Chen Y, Shi Y, Wu L, Tan Y, Li T, Chen Y, et al. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway. J Clin Invest. 2023;133(3)

Hashemi M, Aparviz R, Beickzade M, Paskeh MDA, Kheirabad SK, Koohpar ZK, Moravej A, et al. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery. Biomed Pharmacother. 2023;169: 115927.

Article  PubMed  CAS  Google Scholar 

Hu X, Ma Z, Xu B, Li S, Yao Z, Liang B, Wang J, et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun (Lond). 2023;43(8):909–37.

Article  PubMed  Google Scholar 

Liu J, Yuan Q, Guo H, Guan H, Hong Z, Shang D. Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives. Biomed Pharmacother. 2024;173: 116310.

Article  PubMed  CAS  Google Scholar 

Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, Li M, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52: 102317.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang S, Chen W, Yu H, Song Z, Li Q, Shen X, Wu Y, et al. lncRNA ROR promotes gastric cancer drug resistance. Cancer Control. 2020;27(1):1073274820904694.

Article  PubMed  PubMed Central  Google Scholar 

Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, Wang H, et al. Circumventing drug resistance in gastric cancer: a spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics. Drug Resist Updat. 2024;74: 101080.

Article  PubMed  CAS  Google Scholar 

Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang Z, Zhang H, et al. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets. 2017;21(11):1063–75.

Article  PubMed  CAS  Google Scholar 

Zheng Y, Li Z, Wang Y, Chen W, Lin Y, Guo J, Ye G. CircRNA: A new class of targets for gastric cancer drug resistance therapy. Pathol Oncol Res. 2023;29:1611033.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang X, Zhang J, Cao G, Hua J, Shan G, Lin W. Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance. J Exp Clin Cancer Res. 2022;41(1):218.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lu Y, Jin Z, Hou J, Wu X, Yu Z, Yao L, Pan T, et al. Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer. Matrix Biol. 2023;115:1–15.

Article  PubMed  CAS  Google Scholar 

Zhang Q, Zhang H, Ning T, Liu D, Deng T, Liu R, Bai M, et al. Exosome-delivered c-Met siRNA could reverse chemoresistance to cisplatin in gastric cancer. Int J Nanomed. 2020;15:2323–35.

Article  CAS  Google Scholar 

Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):20.

Article  PubMed  PubMed Central  Google Scholar 

Yao H, Sun L, Li J, Zhou X, Li R, Shao R, Zhang Y, et al. A novel therapeutic siRNA nanoparticle designed for dual-targeting CD44 and Gli1 of gastric cancer stem cells. Int J Nanomed. 2020;15:7013–34.

Article  CAS  Google Scholar 

Wenying Z, Zhaoning J, Zhimin Y, Dongyun C, Lili S. Survivin siRNA inhibits gastric cancer in nude mice. Cell Biochem Biophys. 2012;62(2):337–41.

Article  PubMed  Google Scholar 

Reza MN, Mahmud S, Ferdous N, Ahammad I, Hossain MU, Al Amin M, Mohiuddin AKM. Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer. Cancer Med. 2023;12(24):22407–19.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun Y, Guo BF, Xu LB, Zhong JT, Liu ZW, Liang H, Wen NY, et al. Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo. Cell Biochem Funct. 2015;33(7):495–502.

Article  PubMed  CAS  Google Scholar 

Wang XT, Xie YB, Xiao Q. siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells. World J Gastroenterol. 2012;18(16):1903–14.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fan L, Tan B, Li Y, Zhao Q, Liu Y, Wang D, Zhang Z. Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823. Int J Clin Exp Pathol. 2015;8(10):12428–36.

PubMed  PubMed Central  CAS  Google Scholar 

Fonseca Cabral G, Azevedo Dos Santos Pinheiro J, Vidal AF, Santos S, Ribeiro-Dos-Santos Â. piRNAs in Gastric Cancer: A New Approach Towards Translational Research. Int J Mol Sci. 2020;21(6)

Mirzaei S, Mahabady MK, Zabolian A, Abbaspour A, Fallahzadeh P, Noori M, Hashemi F, et al. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems. Life Sci. 2021;275: 119368.

Article  PubMed  CAS  Google Scholar 

Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Hushmandi K, Rahmanian V, Entezari M, et al. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: approaching to a new era of cancer chemotherapy. Life Sci. 2021;277: 119430.

Article  PubMed  CAS  Google Scholar